Search Results - "Soska, V"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Familial hypercholesterolemia in the Czech Republic: more than 17 years of systematic screening within the MedPed project by Vrablík, M, Vaclová, M, Tichý, L, Soška, V, Bláha, V, Fajkusová, L, Češka, R, Šatný, M, Freiberger, T

    Published in Physiological research (01-01-2017)
    “…Familial hypercholesterolemia (FH) is the most common autosomal dominant disorder. It is characterized by a decrease in LDL cholesterol catabolism and an early…”
    Get full text
    Journal Article
  8. 8

    Phagocyte-derived oxidants and plasma antioxidants in haemodialysed patients by Soska, V., Ciz, M., Kubala, L., Sobotova, D., Lojek, A.

    “…Objective. Oxidative stress is one of the important complications occurring in haemodialysis. The aim of the study was to determine haemodialysis-induced…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Laboratory markers of metabolic syndrome in clinical practice by Soska, V

    Published in Vnitřní lékar̆stvĭ (01-07-2009)
    “…The incidence of metabolic syndrome is evidenced by the presence of three out of five criteria: larger waistline, elevated blood pressure, raised triglyceride…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Secondary dyslipidemias and their treatment by Soska, V

    Published in Vnitřní lékar̆stvĭ (01-04-2007)
    “…Secondary dyslipidemias may develop as a result of other diseases or some major exogenous influences. The most common are secondary dyslipidemias due to the…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Nuclear receptors PPARalpha by Soska, V

    Published in Vnitřní lékar̆stvĭ (01-06-2006)
    “…Mechanism of the fibrates action is mediated by nuclear PPARalpha receptors (Peroxisome Proliferator-Activated Receptor). These receptors regulate a number of…”
    Get more information
    Journal Article